Wave Life Sciences WVE JP — Operating Loss Carryforwards Expiration Year

Similar metrics at other companies

NOVTJP — Open Tax Year

$5050.0%

ADTNOperating Loss Carryforwards Expiration Year

5100.0%

REXOperating Loss Carryorwards Expiration Year

511.8—

CRSPUS — Operating Loss Carryforwards Expiration Period

511.3—

NOVTCA — Operating Loss Carryforward Expiration Year

508.30.0%

TTMIVarious States — Operating Loss Carryforwards Expiration Year

511.30.0%

Questions, answered.

What is Wave Life Sciences's JP — operating loss carryforwards expiration year?

Wave Life Sciences (WVE) reported JP — operating loss carryforwards expiration year of 506.8 in Q4 2025.

How has Wave Life Sciences's JP — operating loss carryforwards expiration year changed year-over-year?

Wave Life Sciences's JP — operating loss carryforwards expiration year increased by 0.1% year-over-year, from 506.3 to 506.8.

What is the long-term trend for Wave Life Sciences's JP — operating loss carryforwards expiration year?

Over 3 years (2022 to 2025), Wave Life Sciences's JP — operating loss carryforwards expiration year has grown at a 0.1% compound annual growth rate (CAGR), from 2K to 2K.

What does JP — operating loss carryforwards expiration year mean?

This metric identifies the calendar year in which the accumulated operating loss carryforwards for the Japan segment are scheduled to expire under local tax regulations. It is a critical indicator of the time horizon available for the company to achieve profitability in this region before the tax benefits are forfeited. Tracking this helps investors evaluate the urgency of operational turnaround and the risk of losing significant tax-advantaged assets.